• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

了解共同存在的慢性疼痛和阿片类药物使用障碍治疗最佳实践的采用障碍和促进因素。

Understanding Barriers and Facilitators to the Uptake of Best Practices for the Treatment of Co-Occurring Chronic Pain and Opioid Use Disorder.

机构信息

Department of Health Behavior, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Department of Social Work, University of Alabama, Tuscaloosa, Alabama, USA.

出版信息

J Dual Diagn. 2020 Apr-Jun;16(2):239-249. doi: 10.1080/15504263.2019.1675920. Epub 2019 Nov 26.

DOI:10.1080/15504263.2019.1675920
PMID:31769729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10763074/
Abstract

: Patients with a combination of chronic pain and opioid use disorder have unique needs and may present a challenge for clinicians and health care systems. The objective of the present study was to use qualitative methods to explore factors influencing the uptake of best practices for co-occurring chronic pain and opioid use disorder in order to inform a quantitative survey assessing primary care provider capacity to appropriately treat this dual diagnosis. : Guided by the Consolidated Framework for Implementation Research (CFIR), semi-structured qualitative interviews were conducted with 11 primary care providers (PCPs) to inform the development of a questionnaire. Interviews were audio-recorded and transcribed verbatim. Fifteen comments from an open-ended question on the questionnaire were added to the analyses as they described factors that were not elucidated in the interviews. Barriers and facilitators were identified and categorized using the CFIR codebook. : The most frequently described barriers were cost and inadequate access to appropriate treatments, external policies, and available resources (e.g., risk assessment tools). The most frequently described facilitators were the presence of a network or team, patient-specific needs, and the learning climate. Knowledge and beliefs were frequently described as both barriers and facilitators. : While substantial funding has been allocated to initiatives aimed at increasing PCP capacity to treat this population, numerous barriers to adopting appropriate practices still exist. Future research should focus on developing and testing implementation strategies that leverage the facilitators and overcome the barriers illustrated here to improve the uptake of evidence-based recommendations for the treatment of co-occurring chronic pain and opioid use disorder.

摘要

:患有慢性疼痛和阿片类药物使用障碍的患者具有独特的需求,可能会给临床医生和医疗保健系统带来挑战。本研究的目的是使用定性方法探讨影响共同发生的慢性疼痛和阿片类药物使用障碍最佳实践采用的因素,为评估初级保健提供者适当治疗这种双重诊断的能力的定量调查提供信息。:本研究以实施研究综合框架(CFIR)为指导,对 11 名初级保健提供者(PCP)进行了半结构化定性访谈,以了解问卷的制定。访谈进行了录音,并逐字转录。在问卷的一个开放式问题中添加了 15 条评论,以补充分析,因为这些评论描述了访谈中未阐明的因素。使用 CFIR 编码簿识别和分类障碍和促进因素。:描述最多的障碍是成本和适当治疗方法的获取不足、外部政策和可用资源(例如,风险评估工具)。描述最多的促进因素是网络或团队的存在、患者的特定需求和学习氛围。知识和信念经常被描述为障碍和促进因素。:虽然已经为旨在提高初级保健提供者治疗该人群能力的举措分配了大量资金,但采用适当做法仍然存在许多障碍。未来的研究应侧重于开发和测试实施策略,利用这里说明的促进因素并克服障碍,以提高对共同发生的慢性疼痛和阿片类药物使用障碍的治疗的循证建议的采用。

相似文献

1
Understanding Barriers and Facilitators to the Uptake of Best Practices for the Treatment of Co-Occurring Chronic Pain and Opioid Use Disorder.了解共同存在的慢性疼痛和阿片类药物使用障碍治疗最佳实践的采用障碍和促进因素。
J Dual Diagn. 2020 Apr-Jun;16(2):239-249. doi: 10.1080/15504263.2019.1675920. Epub 2019 Nov 26.
2
Development and validation of the Capacity to Treat Chronic Pain and Opioid Use Disorder (CAP-POD) questionnaire.慢性疼痛治疗能力与阿片类药物使用障碍(CAP-POD)问卷的开发与验证
Implement Res Pract. 2020 Sep 15;1:2633489520948859. doi: 10.1177/2633489520948859. eCollection 2020 Jan-Dec.
3
Exploring the facilitators and barriers in opioid deprescribing for non-cancer pain treatment experienced by general practitioners: A qualitative study.探讨全科医生在非癌性疼痛治疗中减少阿片类药物使用的促进因素和障碍:一项定性研究。
Eur J Pain. 2024 Aug;28(7):1101-1115. doi: 10.1002/ejp.2243. Epub 2024 Jan 30.
4
Barriers to guideline-concordant opioid management in primary care--a qualitative study.基层医疗中符合指南的阿片类药物管理的障碍——一项定性研究
J Pain. 2014 Nov;15(11):1148-1155. doi: 10.1016/j.jpain.2014.08.006. Epub 2014 Aug 29.
5
Barriers and facilitators to office-based opioid agonist therapy prescribing and effective interventions to increase provider prescribing: protocol for a systematic review.基于诊所在职的阿片类激动剂治疗处方的障碍和促进因素,以及增加提供者处方的有效干预措施:系统评价方案。
Syst Rev. 2019 Jul 25;8(1):186. doi: 10.1186/s13643-019-1076-7.
6
Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping review.阿片类激动剂治疗中丁丙诺啡使用的障碍和促进因素:系统评价方案。
BMJ Open. 2019 Dec 15;9(12):e032285. doi: 10.1136/bmjopen-2019-032285.
7
Utilization and Costs by Primary Care Provider Type: Are There Differences Among Diabetic Patients of Physicians, Nurse Practitioners, and Physician Assistants?主要医疗服务提供类型的利用情况和费用:医生、执业护士和医师助理的糖尿病患者之间是否存在差异?
Med Care. 2020 Aug;58(8):681-688. doi: 10.1097/MLR.0000000000001326.
8
When human immunodeficiency virus (HIV) treatment goals conflict with guideline-based opioid prescribing: A qualitative study of HIV treatment providers.当人类免疫缺陷病毒(HIV)治疗目标与基于指南的阿片类药物处方发生冲突时:对HIV治疗提供者的定性研究。
Subst Abus. 2016;37(1):148-53. doi: 10.1080/08897077.2015.1129391.
9
Inequities in access to primary care among opioid recipients in Ontario, Canada: A population-based cohort study.加拿大安大略省阿片类药物使用者获得初级保健服务的不平等:基于人群的队列研究。
PLoS Med. 2021 Jun 1;18(6):e1003631. doi: 10.1371/journal.pmed.1003631. eCollection 2021 Jun.
10
Primary care clinicians' experiences with treatment decision making for older persons with multiple conditions.基层医疗临床医生针对患有多种疾病的老年人进行治疗决策的经历。
Arch Intern Med. 2011 Jan 10;171(1):75-80. doi: 10.1001/archinternmed.2010.318. Epub 2010 Sep 13.

引用本文的文献

1
Opioid analgesics for chronic noncancer pain in patients prescribed opioid agonist therapy or with opioid use disorder: A systematic review.用于接受阿片类激动剂治疗或患有阿片类药物使用障碍患者的慢性非癌性疼痛的阿片类镇痛药:一项系统评价。
Can J Pain. 2025 Jul 31;9(1):2499553. doi: 10.1080/24740527.2025.2499553. eCollection 2025.
2
Empowering Primary Care Nurse Practitioners: A Multilevel Approach to Combating the Opioid Crisis.增强初级护理执业护士的能力:应对阿片类药物危机的多层次方法。
J Adv Nurs. 2024 Dec 22;81(6):3405-13. doi: 10.1111/jan.16694.
3
Recent advances in the treatment of chronic pain and substance use disorders.慢性疼痛与物质使用障碍治疗的最新进展
Curr Opin Psychol. 2025 Apr;62:101977. doi: 10.1016/j.copsyc.2024.101977. Epub 2024 Dec 13.
4
The perpetual evidence-practice gap: addressing ongoing barriers to chronic pain management in primary care in three steps.长期存在的证据与实践差距:分三步解决初级保健中慢性疼痛管理的持续障碍。
Front Pain Res (Lausanne). 2024 Oct 8;5:1376462. doi: 10.3389/fpain.2024.1376462. eCollection 2024.
5
The Association Between Chronic Pain, Substance use, and Primary Care Experience Among Veterans with Ongoing or Recent Homelessness.有持续或近期无家可归经历的退伍军人中慢性疼痛、物质使用与初级保健体验之间的关联。
J Gen Intern Med. 2024 Dec;39(16):3172-3181. doi: 10.1007/s11606-024-09078-x. Epub 2024 Oct 15.
6
Physician Reluctance to Intervene in Addiction: A Systematic Review.医生对成瘾干预的抵触情绪:一项系统综述。
JAMA Netw Open. 2024 Jul 1;7(7):e2420837. doi: 10.1001/jamanetworkopen.2024.20837.
7
Provider Perspectives of Facilitators and Barriers to Reaching and Utilizing Chronic Pain Healthcare for Persons With Traumatic Brain Injury: A Qualitative NIDILRR and VA TBI Model Systems Collaborative Project.提供者对创伤性脑损伤患者获得和利用慢性疼痛医疗保健的促进因素和障碍的看法:一个 NIDILRR 和 VA TBI 模型系统合作项目。
J Head Trauma Rehabil. 2024;39(1):E15-E28. doi: 10.1097/HTR.0000000000000923.
8
Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model.招募农村初级保健提供者以实施专注于阿片类药物使用障碍药物治疗(MOUD)的综合护理模式的策略。
Implement Res Pract. 2023 Feb 19;4:26334895231152808. doi: 10.1177/26334895231152808. eCollection 2023 Jan-Dec.
9
Development and validation of the Capacity to Treat Chronic Pain and Opioid Use Disorder (CAP-POD) questionnaire.慢性疼痛治疗能力与阿片类药物使用障碍(CAP-POD)问卷的开发与验证
Implement Res Pract. 2020 Sep 15;1:2633489520948859. doi: 10.1177/2633489520948859. eCollection 2020 Jan-Dec.
10
Assessing the Acceptability of Yoga Among Patients with and without Chronic Pain Enrolled in a Licensed Opioid Treatment Program.评估参加持牌阿片类药物治疗项目的慢性疼痛患者与非慢性疼痛患者对瑜伽的接受程度。
Int J Yoga Therap. 2022 Jan 1;32(2022). doi: 10.17761/2022-D-21-00055.

本文引用的文献

1
Prevalence and Profile of High-Impact Chronic Pain in the United States.美国高影响慢性疼痛的流行情况和特征。
J Pain. 2019 Feb;20(2):146-160. doi: 10.1016/j.jpain.2018.07.006. Epub 2018 Aug 7.
2
Medicaid Benefits For Addiction Treatment Expanded After Implementation Of The Affordable Care Act.《平价医疗法案》实施后,医疗补助的成瘾治疗福利扩大。
Health Aff (Millwood). 2018 Aug;37(8):1216-1222. doi: 10.1377/hlthaff.2018.0272.
3
A crisis of opioids and the limits of prescription control: United States.阿片类药物危机和处方控制的局限性:美国。
Addiction. 2019 Jan;114(1):169-180. doi: 10.1111/add.14394. Epub 2018 Aug 27.
4
Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff.影响初级保健诊所实施物质使用筛查的障碍和促进因素:对患者、提供者和工作人员的定性研究。
Addict Sci Clin Pract. 2018 Apr 9;13(1):8. doi: 10.1186/s13722-018-0110-8.
5
Trends in Medical Use of Opioids in the U.S., 2006-2016.美国 2006-2016 年阿片类药物医疗使用趋势。
Am J Prev Med. 2018 May;54(5):652-660. doi: 10.1016/j.amepre.2018.01.034. Epub 2018 Mar 15.
6
A randomized matched-pairs study of feasibility, acceptability, and effectiveness of systems consultation: a novel implementation strategy for adopting clinical guidelines for Opioid prescribing in primary care.一项系统咨询的可行性、可接受性和有效性的随机匹配对研究:一种在初级保健中采用阿片类药物处方临床指南的新型实施策略。
Implement Sci. 2018 Jan 25;13(1):21. doi: 10.1186/s13012-018-0713-1.
7
Managing Concerning Behaviors in Patients Prescribed Opioids for Chronic Pain: A Delphi Study.管理慢性疼痛患者处方阿片类药物的相关行为:德尔菲研究。
J Gen Intern Med. 2018 Feb;33(2):166-176. doi: 10.1007/s11606-017-4211-y. Epub 2017 Dec 4.
8
Use and Misuse of Opioids in Chronic Pain.慢性疼痛中阿片类药物的使用与误用。
Annu Rev Med. 2018 Jan 29;69:451-465. doi: 10.1146/annurev-med-011817-044739. Epub 2017 Oct 13.
9
Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiatives.健康计划实施阿片类药物剂量和风险降低举措后,慢性阿片类药物治疗患者中处方阿片类药物使用障碍的患病率。
Int J Drug Policy. 2017 Aug;46:90-98. doi: 10.1016/j.drugpo.2017.05.053. Epub 2017 Jun 27.
10
Training internal medicine residents to manage chronic pain and prescription opioid misuse.培训内科住院医师管理慢性疼痛和处方阿片类药物滥用问题。
Subst Abus. 2017 Apr-Jun;38(2):200-204. doi: 10.1080/08897077.2017.1296526. Epub 2017 Apr 10.